GBCIX
Price
$17.43
Change
-$0.03 (-0.17%)
Updated
Jun 5 closing price
Net Assets
18.64M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

GBCIX vs RMEBX

Header iconGBCIX vs RMEBX Comparison
Open Charts GBCIX vs RMEBXBanner chart's image
Gabelli Dividend Growth I
Price$17.43
Change-$0.03 (-0.17%)
VolumeN/A
Net Assets18.64M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
GBCIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GBCIX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBCIX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. GBCIX (18.6M). RMEBX pays higher dividends than GBCIX: RMEBX (1.16) vs GBCIX (0.60). GBCIX was incepted earlier than RMEBX: GBCIX (21 years) vs RMEBX (11 years). GBCIX (2.40) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. GBCIX (23.00). RMEBX has a lower initial minimum investment than GBCIX: RMEBX (250) vs GBCIX (10000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. GBCIX (-3.44). RMEBX return over 5 years is better than : 49.85 vs. GBCIX (19.61).
GBCIXRMEBXGBCIX / RMEBX
Total Expense Ratio1.001.0793%
Annual Report Gross Expense Ratio2.401.07224%
Fund Existence21 years11 years-
Gain YTD3.0705.34957%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.6M105B0%
Annual Yield % from dividends0.601.1651%
Returns for 1 year-3.448.30-41%
Returns for 3 years5.2817.9629%
Returns for 5 years19.6149.8539%
Returns for 10 years-0.3168.21-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA